Elena Petersen, Head of the MIPT Center for Biomedical Technologies, emphasized that the new system is primarily beneficial for cancer patients and can be an effective tool in choosing individual treatment strategies. It allows you to extract cells and tissue from a patient’s body and then test their response to medications. This is an important step, especially in the treatment of cancer and post-Covid syndrome.
The press service noted that the system takes into account the phenomenon of cellular aging and the consequences of viral diseases, which makes it possible to predict the body’s response to treatment. This creates new opportunities for more effective treatment and reducing the risk of complications.
Source: Ferra
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
